KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to 0.07.

  • Organon's Equity Ratio rose 7292.44% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year increase of 7292.44%. This contributed to the annual value of 0.04 for FY2024, which is 72060.43% up from last year.
  • Per Organon's latest filing, its Equity Ratio stood at 0.07 for Q3 2025, which was up 7292.44% from 0.05 recorded in Q2 2025.
  • Organon's Equity Ratio's 5-year high stood at 0.49 during Q1 2021, with a 5-year trough of 0.18 in Q2 2021.
  • Moreover, its 5-year median value for Equity Ratio was 0.05 (2023), whereas its average is 0.02.
  • In the last 5 years, Organon's Equity Ratio tumbled by 12601.61% in 2021 and then soared by 92059.29% in 2025.
  • Quarter analysis of 5 years shows Organon's Equity Ratio stood at 0.14 in 2021, then surged by 42.33% to 0.08 in 2022, then soared by 92.87% to 0.01 in 2023, then soared by 720.6% to 0.04 in 2024, then soared by 85.56% to 0.07 in 2025.
  • Its Equity Ratio stands at 0.07 for Q3 2025, versus 0.05 for Q2 2025 and 0.04 for Q1 2025.